These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1892747)

  • 1. The effects of vasopressin infusion on hepatic haemodynamics in an experimental model of liver metastases.
    Hemingway DM; Chang D; Cooke TG; Jenkins SA
    Br J Cancer; 1991 Aug; 64(2):212-4. PubMed ID: 1892747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of sandostatin (Octreotide, SMS 201-995) infusion on splanchnic and hepatic blood flow in an experimental model of hepatic metastases.
    Hemingway DM; Jenkins SA; Cooke TG
    Br J Cancer; 1992 Mar; 65(3):396-8. PubMed ID: 1558793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide inhibition sustains vasopressin-induced vasoconstriction.
    Dworkin MJ; Carnochan P; Allen-Mersh TG
    Br J Cancer; 1995 May; 71(5):942-4. PubMed ID: 7734317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of vasopressin and hepatic artery ligation on the blood supply to normal and metastatic liver tissue.
    Jenkins SA; Day DW; Mooney B; Devitt P; Taylor I; Shields R
    Br J Cancer; 1984 Dec; 50(6):785-91. PubMed ID: 6498075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in hepatic haemodynamics and hepatic perfusion index during the growth and development of hypovascular HSN sarcoma in rats.
    Hemingway DM; Cooke TG; Grime SJ; Nott DM; Jenkins SA
    Br J Surg; 1991 Mar; 78(3):326-30. PubMed ID: 2021849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in liver blood flow associated with the growth of hepatic LV10 and MC28 sarcomas in rats.
    Hemingway DM; Cooke TG; Grime SJ; Jenkins SA
    Br J Surg; 1993 Apr; 80(4):495-8. PubMed ID: 8495321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin-induced changes in splanchnic blood flow and hepatic and portal venous pressures in liver resection.
    Bown LS; Ricksten SE; Houltz E; Einarsson H; Söndergaard S; Rizell M; Lundin S
    Acta Anaesthesiol Scand; 2016 May; 60(5):607-15. PubMed ID: 26763649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood flow in experimental liver tumors: effect of vasoactive drugs.
    Hafström L; Persson B; Sundqvist K
    Acta Chir Scand; 1980; 146(3):149-53. PubMed ID: 7468035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin: route of administration and effects on canine hepatic and superior mesenteric arterial blood flows.
    Kerr JC; Hobson RW; Seelig RF; Swan KG
    Ann Surg; 1978 Feb; 187(2):137-42. PubMed ID: 147062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of octreotide infusion on hepatic and tumour blood flow in two experimental models of liver metastases.
    Davies N; Kynaston H; Yates J; Nott DM; Taylor BA; Jenkins SA
    Eur J Gastroenterol Hepatol; 1995 Oct; 7(10):971-4. PubMed ID: 8590143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vasopressin on liver blood flow in the hypophysectomised rat.
    Jenkins SA; Mooney B; Taylor I; Shields R
    Digestion; 1984; 29(3):177-82. PubMed ID: 6745509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in hepatic haemodynamics in rats with overt liver tumour.
    Nott DM; Grime SJ; Yates J; Baxter JN; Cooke TG; Jenkins SA
    Br J Cancer; 1991 Dec; 64(6):1088-92. PubMed ID: 1764371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow.
    Wisén E; Svennerholm K; Bown LS; Houltz E; Rizell M; Lundin S; Ricksten SE
    Acta Anaesthesiol Scand; 2018 Aug; 62(7):953-961. PubMed ID: 29578250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a relationship between regional microsphere distribution and hepatic arterial blood flow?
    Anderson JH; Angerson WJ; Willmott N; Kerr DJ; McArdle CS; Cooke TG
    Br J Cancer; 1992 Aug; 66(2):287-9. PubMed ID: 1503900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vasopressin on regional splanchnic blood flows in conscious man.
    Erwald R; Wiechel KL; Strandell T
    Acta Chir Scand; 1976; 142(1):36-42. PubMed ID: 1266541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of vasopressin on hepatic artery flow in the rat.
    Jenkins SA; Mooney B; Devitt P; Taylor I; Shields R
    Clin Exp Pharmacol Physiol; 1984; 11(5):521-6. PubMed ID: 6525767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of intra-arterial and intraportal injections of vasopressin on the simultaneously perfused hepatic arterial and portal venous vascular beds of the dog.
    Richardson PD; Withrington PG
    Circ Res; 1978 Oct; 43(4):496-503. PubMed ID: 688553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of regional angiotensin-II: a novel biologic response modifier.
    Wu Y; Sitzmann JV
    Ann Surg Oncol; 1996 Jan; 3(1):24-8. PubMed ID: 8770298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow.
    Dworkin MJ; Carnochan P; Allen-Mersh TG
    Br J Cancer; 1997; 76(9):1205-10. PubMed ID: 9365170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of vasopressin on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
    Jenkins SA; Day DW; Mooney B; Devitt P; Baxter JN; Taylor I; Shields R
    Langenbecks Arch Chir; 1985; 365(2):135-46. PubMed ID: 4046683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.